APA (7th ed.) Citation

Castleton, P., Gyawali, P., Mathews, N., Mutuku, S. M., Sharkey, D. J., & McPherson, N. O. (2023). MiOXSYS® and OxiSperm® II assays appear to provide no clinical utility for determining oxidative stress in human sperm—results from repeated semen collections. Andrology, 11(8), 1566. https://doi.org/10.1111/andr.13356

Chicago Style (17th ed.) Citation

Castleton, Patience, Prabin Gyawali, Nicola Mathews, Shadrack Mulinge Mutuku, David James Sharkey, and Nicole Olivia McPherson. "MiOXSYS® and OxiSperm® II Assays Appear to Provide No Clinical Utility for Determining Oxidative Stress in Human Sperm—results from Repeated Semen Collections." Andrology 11, no. 8 (2023): 1566. https://doi.org/10.1111/andr.13356.

MLA (9th ed.) Citation

Castleton, Patience, et al. "MiOXSYS® and OxiSperm® II Assays Appear to Provide No Clinical Utility for Determining Oxidative Stress in Human Sperm—results from Repeated Semen Collections." Andrology, vol. 11, no. 8, 2023, p. 1566, https://doi.org/10.1111/andr.13356.